Return to search

Tragara Pharma Raises $40 Million

Tragara Pharmaceuticals Inc., a San Diego-based drug company focused on cancer and inflammatory diseases, has raised $40 million in Series A funding. Backers include Domain Associates, ProQuest Investments, Morgenthaler Ventures, Oxford Biosceince Partners and Mitsubishi International Corp. www.tragarapharma.com